Latest on Pharmaceutical Industry


Novo Nordisk's diabetes drug succeeds in key trial

Novo Nordisk A/S said on Wednesday its diabetes drug met the main goal of reducing glucose levels in patients in a key late-stage trial, setting the stage for it to become the new standard therapy for type 2 diabetes. ..Read More...

L.E.A.F. Pharmaceuticals Establishes its First Subsidiary in Rwanda

L.E.A.F. Pharmaceuticals LLC, a global pharmaceutical company located in the historic area of Valley Forge, Pennsylvania, USA, with a mission to discover, develop and commercialize innovative and safe therapies for cance..Read More...



International Conference & Exhibition of the Modernization of Chinese Medicine & Health Products 2017

Hong Kong Convention and Exhibition Centre,
Hong Kong,



Saigon Exhibition and Conferences Center,
National Trade Fair & Advertising JSC

Press Releases

Achieve Announces Initiation of Cytisine Clinical Development Program

Achieve Life Sciences Inc a clinicalstage pharmaceutical company committed to the global development and commercialization of cytisine for smoking cessation today announced initiation of the Cytisine Clinical Development.. Read More...

Medpace Holdings, Inc. Announces Stock Repurchase Agreement with Cinven

Medpace Holdings Inc today announced it has entered into a stock repurchase agreement the Stock Repurchase Agreement with investment funds affiliated with Cinven Capital Management V General Partner Limited Cinven Und.. Read More...

Suppliers of the Month

Product Launch



Latest Reports


Latest Projects


Expert Talk

Bayer Pharmaceuticals

Bayer Pharmaceuticals Christoph Huwe PhD CAAM is a Strategic Alliance Manager Therapeutics at Bayer AG Pharmaceuticals with a focus on the BayerEvotec Endometriosis BayerEvotec Kidney Diseases BayerOncoMed Oncology strategic alliances and the Tuberculosis Drug Accelerator consortium He is also a member of Bayers Alliance. Read More...
Christoph Huwe
Strategic Alliance Manager Therapeutics